Trial Condition(s):

Dermatitis, Atopic

Efficacy and tolerance of once-daily methylprednisolone aceponate ointment in comparison with twice-daily hydrocortisone 17-butyrate in patients with atopic dermatitis

Bayer Identifier:

Trial_89172

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

213

Trial Dates

February1990

December1990

Phase

Could I receive a placebo?

Products

Advantan (Methylprednisolone Aceponate, BAY86-4862)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Locations

For details, please refer to trial results

Additional Information

Not Available

Dermatitis, Atopic

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

15 Years

No Limit

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information